Dr. Ghiath Mahmaljy, MD (he/him) is an Endocrinologist in Brooksville, FL with over 16 years of experience. What is your opinion of Dr. Ghiath Mahmaljy, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Ghiath Mahmaljy, MD has received over $10,564 which includes payments from the following companies:
$3,083.52 from Novo Nordisk Inc
$2,526.83 from GlaxoSmithKline, LLC.
$1,347.47 from sanofi-aventis U.S. LLC
$784.53 from LILLY USA, LLC
$422.51 from Merck Sharp & Dohme Corporation
$405.98 from Janssen Pharmaceuticals, Inc
$348.96 from AstraZeneca Pharmaceuticals LP
$252.83 from Amgen Inc.
$187.83 from Boehringer Ingelheim Pharmaceuticals, Inc.
$158.62 from Medtronic MiniMed, Inc.
$139.95 from AbbVie, Inc.
$122.10 from INSULET CORPORATION
$105.00 from GENZYME CORPORATION
$104.11 from Shire North American Group Inc
$91.74 from Amarin Pharma Inc.
$69.95 from Dexcom, Inc.
$68.87 from Corcept Therapeutics
$67.95 from Abbott Laboratories
$34.29 from MannKind Corporation
$32.67 from Eisai Inc.
Payments received by Dr. Ghiath Mahmaljy, MD were from the following categories:
$7,895.52 Food and Beverage
$2,355.00 Consulting Fee
$175.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!